TECHNOVIEW® Rivaroxaban Cont Low

 

Low control plasmas for the rivaroxaban assay.

TECHNOVIEW® Rivaroxaban Control Low quality control plasmas are titrated to approximately 50 ng / mL, optimized for anti-FXa methods.



Informations

Rivaroxaban is a highly selective direct inhibitor of FXa.
This inhibition interrupts the intrinsic pathway of the blood coagulation cascade, inhibiting the formation of thrombin and the development of thrombi. It does not inhibit thrombin and has no effect on platelets.


Documentation

Download the product sheet
Price list, safety data sheets and notices are accessible to our registered customers.


Lyophilized plasmas
 
 
lyophiliseCEIVDbioHazardstockage_2_8C2j_10_15C7j_2_8Cdistributeur
 

References

4-5090172Vial5 x 1.0 mL